Home › X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG
 

Keywords :   


X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG

2014-12-29 01:28:39| drugdiscoveryonline Home Page

X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, recently announced it has licensed a second drug discovery program to Bayer Pharma AG pursuant to the multi-target collaboration the companies established in July 2012

Tags: program drug discovery licenses

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Ex-cabinet secretary says 200,000 job is underpaid
06.10Hurricane Leslie Graphics
06.10Hurricane Leslie Forecast Discussion Number 16
06.10Hurricane Leslie Wind Speed Probabilities Number 16
06.10Hurricane Leslie Forecast Advisory Number 16
06.10Hurricane Leslie Public Advisory Number 16
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Kirk Graphics
More »